Cargando…

Repositioning of Antiparasitic Drugs for Tumor Treatment

Drug repositioning is a strategy for identifying new antitumor drugs; this strategy allows existing and approved clinical drugs to be innovatively repurposed to treat tumors. Based on the similarities between parasitic diseases and cancer, recent studies aimed to investigate the efficacy of existing...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yan-Qi, Zheng, Zhi, Liu, Quan-Xing, Lu, Xiao, Zhou, Dong, Zhang, Jiao, Zheng, Hong, Dai, Ji-Gang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8117216/ https://www.ncbi.nlm.nih.gov/pubmed/33996598 http://dx.doi.org/10.3389/fonc.2021.670804

Ejemplares similares

Double Repositioning: Veterinary Antiparasitic to Human Anticancer
por: Sultana, Tania, et al.
Publicado: (2022)

Computational drug repositioning for the identification of new agents to sensitize drug-resistant breast tumors across treatments and receptor subtypes
por: Yu, Katharine, et al.
Publicado: (2023)

A Review of Current In Silico Methods for Repositioning Drugs and Chemical Compounds
por: He, Binsheng, et al.
Publicado: (2021)

Repositioning Quinacrine Toward Treatment of Ovarian Cancer by Rational Combination With TRAIL
por: Liang, Rui, et al.
Publicado: (2020)

Colchicine as a novel drug for the treatment of osteosarcoma through drug repositioning based on an FDA drug library
por: Oh, Jisun, et al.
Publicado: (2022)

Screening of Drug Repositioning Candidates for Castration Resistant Prostate Cancer
por: Kim, In-Wha, et al.
Publicado: (2019)

Drug repositioning via host-pathogen protein-protein interactions for the treatment of cervical cancer
por: Kori, Medi, et al.
Publicado: (2023)

Nanoparticles for antiparasitic drug delivery
por: Sun, Yuzhu, et al.
Publicado: (2019)

Antifungal and Antiparasitic Drug Delivery
por: Torrado, Juan José, et al.
Publicado: (2020)

Moesin as a prognostic indicator of lung adenocarcinoma improves prognosis by enhancing immune lymphocyte infiltration
por: Li, Yan-Qi, et al.
Publicado: (2021)

Drug Repositioning for P-Glycoprotein Mediated Co-Expression Networks in Colorectal Cancer
por: Beklen, Hande, et al.
Publicado: (2020)

Editorial: FDA-Approved Drug Repositioning for P-Glycoprotein Overexpressing Resistant Cancer
por: Yoon, Sungpil, et al.
Publicado: (2021)

New Approaches in Oncology for Repositioning Drugs: The Case of PDE5 Inhibitor Sildenafil
por: Cruz-Burgos, Marian, et al.
Publicado: (2021)

Progress in Redirecting Antiparasitic Drugs for Cancer Treatment
por: Huang, Haoyang, et al.
Publicado: (2021)

The Current Directions of Searching for Antiparasitic Drugs
por: Dziduch, Katarzyna, et al.
Publicado: (2022)

New Drug Repositioning Candidates for T-ALL Identified Via Human/Murine Gene Signature Comparison
por: Bonnet, Raphaël, et al.
Publicado: (2020)

A Drug Repositioning Approach Identifies a Combination of Compounds as a Potential Regimen for Chronic Lymphocytic Leukemia Treatment
por: Nehdi, Atef, et al.
Publicado: (2021)

Interplay Between Autophagy and Wnt/β-Catenin Signaling in Cancer: Therapeutic Potential Through Drug Repositioning
por: Pérez-Plasencia, Carlos, et al.
Publicado: (2020)

Drug repositioning: Progress and challenges in drug discovery for various diseases
por: Hua, Yi, et al.
Publicado: (2022)

Pathway-based drug repositioning using causal inference
por: Li, Jiao, et al.
Publicado: (2013)

Repositioning of Hypoglycemic Drug Linagliptin for Cancer Treatment
por: Li, Yong, et al.
Publicado: (2020)

Repositioning Aspirin to Treat Lung and Breast Cancers and Overcome Acquired Resistance to Targeted Therapy
por: Li, Ling, et al.
Publicado: (2020)

Drug repositioning in sarcomas and other rare tumors
por: Lee, Alex T.J., et al.
Publicado: (2016)

Drug Repositioning for Hand, Foot, and Mouth Disease
por: Yan, Ran, et al.
Publicado: (2022)

How Antiparasitic Drugs Work—And Sometimes Stop Working!
por: Horn, David
Publicado: (2016)

Bisphosphonate-Based Molecules as Potential New Antiparasitic Drugs
por: Branco Santos, Joice Castelo, et al.
Publicado: (2020)

Ultra-Performance Liquid Chromatography/Mass Spectrometry-Based Metabolomics for Discovering Potential Biomarkers and Metabolic Pathways of Colorectal Cancer in Mouse Model (ApcMin/+) and Revealing the Effect of Honokiol
por: Chen, Xin, et al.
Publicado: (2021)

Network mirroring for drug repositioning
por: Park, Sunghong, et al.
Publicado: (2017)

Ivermectin, a potential anticancer drug derived from an antiparasitic drug
por: Tang, Mingyang, et al.
Publicado: (2021)

Repositioning Drugs for Psychiatry
por: Akhondzadeh, Shahin
Publicado: (2020)

MNBDR: A Module Network Based Method for Drug Repositioning
por: Chen, He-Gang, et al.
Publicado: (2020)

Drug repositioning: A bibliometric analysis
por: Sun, Guojun, et al.
Publicado: (2022)

Macromolecular crystallography and what it can contribute to antiparasite drug discovery
por: Hunter, W. N., et al.
Publicado: (2015)

Antiparasitic Drugs in the United States—Two Roads to High Prices
por: Shahriar, Arman A., et al.
Publicado: (2020)

The Pattern of Blood–Milk Exchange for Antiparasitic Drugs in Dairy Ruminants
por: Imperiale, Fernanda, et al.
Publicado: (2021)

Repositioned Drugs for Chagas Disease Unveiled via Structure-Based Drug Repositioning
por: Adasme, Melissa F., et al.
Publicado: (2020)

Drug repositioning in drug discovery of T2DM and repositioning potential of antidiabetic agents
por: Zhu, Sha, et al.
Publicado: (2022)

Beyond TNBC: Repositioning of Clofazimine Against a Broad Range of Wnt-Dependent Cancers
por: Xu, Jiabin, et al.
Publicado: (2020)

The Immunogenetics of Psoriasis and Implications for Drug Repositioning
por: Xu, Xuan, et al.
Publicado: (2017)

Large-scale Direct Targeting for Drug Repositioning and Discovery
por: Zheng, Chunli, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_k1idbqrh6mqffmfr0ci5bnkg6s